Keywords
How to Cite
Abstract
Chronic hepatitis B (CHB) remains a significant global health burden, affecting approximately 296 million people worldwide. The progression of liver fibrosis in CHB patients often follows a latent course, making early detection crucial for preventing cirrhosis and hepatocellular carcinoma. While liver biopsy remains the gold standard for fibrosis assessment, its invasive nature has prompted the development of noninvasive diagnostic methods. This study aims to comparatively evaluate the diagnostic accuracy, clinical utility, and cost-effectiveness of three noninvasive methods—APRI (AST to Platelet Ratio Index), FIB-4 (Fibrosis-4 Index), and FibroScan (transient elastography)—in detecting and monitoring the latent progression of liver fibrosis in CHB patients.
References
1. Ahsan, R., & Mansoor ul Haq. (2025). APRI (AST to platelet ratio index) and (fibrosis-4 index) performance to assess liver fibrosis against predefined fibroscan values in chronic hepatitis C virus infection. Professional Medical Journal, 32(5), 545-550.
2. Bedogni, G., Miglioli, L., Masutti, F., Castiglione, A., Crocè, L. S., Tiribelli, C., & Bellentani, S. (2023). AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. Gastroenterology and Hepatology from Bed to Bench, 16(2), 112-119. doi: 10.22037/ghfbb.v16i2.2658
3. Cardoso, A. C., Moucari, R., Figueiredo-Mendes, C., Ripault, M. P., Giuily, N., Castelnau, C., ... & Marcellin, P. (2021). A comparative analysis of the APRI, FIB4, and FibroScan score in evaluating the severity of chronic liver disease in chronic hepatitis B patients in India. Journal of Clinical and Experimental Hepatology, 11(6), 678-685.
4. European Association for the Study of the Liver. (2022). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology, 76(2), 433-486.
5. Fang, C., Sidali, S., Barth, D., Carbonneau, M., Gomaa, A., Saleh, M., ... & Wong, D. K. (2024). Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9(4), 298-312.
6. Huang, R., Jiang, N., Yang, R., Geng, X., Lin, J., Xu, G., ... & Lu, L. (2021). Fibroscan improves the diagnosis of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology, 27(30), 5045-5060.
This work is licensed under a Creative Commons Attribution 4.0 International License.